Skip to main content
ACON
NASDAQ Life Sciences

Aclarion 报告 196% 的 Q1 扫描量增长，拥有 1,900 万美元现金，无债务的微型上市公司

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
9
Price
$3.32
Mkt Cap
$7.441M
52W Low
$2.34
52W High
$12.03
Market data snapshot near publication time

summarizeSummary

Aclarion 报告了强劲的 Q1 2026 年度结果，亮点包括 Nociscan 扫描量同比增长 196% 和按季度增长 64%，表明临床采用率正在加速。该公司还披露了强劲的财务状况，截至 2026 年 3 月 31 日，现金为 1,900 万美元，无未偿债务，为 2027 年下半年提供了足够的资金。这一积极的运营和财务更新是在最近获得专利和 250 万美元股份回购计划的消息之后，这预示着战略执行的时期。显著的扫描量增长验证了 Nociscan 的商业战略，而大量的现金余额远远超过了公司当前的市场资本化，为未来增长提供了强大的财务稳定性和灵活性。投资者应该关注 Nociscan 的持续采用、CLARITY 随机试验的进展（预计 2026 年下半年公布初步结果）以及美国付款人报销的进一步发展。

在该公告发布时，ACON的交易价格为$3.32，交易所为NASDAQ，所属行业为Life Sciences，市值约为$744.1万。 52周交易区间为$2.34至$12.03。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed ACON - Latest Insights

ACON
Apr 30, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Aclarion Reports 196% Q1 Scan Volume Growth, Boasts $19M Cash with No Debt for Micro-Cap
Sentiment: Positive
View Wiseek Article
ACON
Apr 27, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Significant Equity Plan Expansion, Authorizing 18.56% Potential Dilution
Sentiment: Negative
View Wiseek Article
ACON
Apr 22, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Authorizes $2.5M Share Repurchase Program, Signaling Confidence
Sentiment: Positive
View Wiseek Article
ACON
Apr 16, 2026, 6:47 AM EDT
Source: GlobeNewswire
Importance Score:
8
Aclarion Secures Key U.S. Patent for AI-Driven Chronic Back Pain Assessment Platform
Sentiment: Positive
View Wiseek Article
ACON
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan AI Technology Wins Pinnacle Award for Innovation
Sentiment: Positive
View Wiseek Article
ACON
Apr 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan Nears 100 Scans at London Clinic, Signaling Growing Adoption
Sentiment: Positive
View Wiseek Article
ACON
Apr 03, 2026, 5:02 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Major Equity Plan Expansion and Re-election of Contested Director
Sentiment: Negative
View Wiseek Article
ACON
Mar 24, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Activist Investor Demands Board Member Resignation at Aclarion Amid 99% Stock Decline
Sentiment: Negative
View Wiseek Article
ACON
Mar 19, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Adopts 'Poison Pill' Stockholder Rights Plan to Deter Hostile Takeovers
Sentiment: Negative
View Wiseek Article
ACON
Jan 13, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Aclarion Secures $10.4M Financing at Premium, Extends Cash Runway into 2028
Sentiment: Positive
View Wiseek Article